NAGE (NAGE) AI Dilution Summary

Niagen Bioscience held cash of $66,740,000 at the last reported balance-sheet date (2026-06-30), and funds itself through an active at-the-market program with Canaccord Genuity LLC and Roth Capital Partners, LLC authorised to $50,000,000, of which $0 has been sold to date.